Advertisement
UK markets open in 40 minutes
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,730.45
    +445.91 (+2.58%)
     
  • CRUDE OIL

    84.01
    +0.44 (+0.53%)
     
  • GOLD FUTURES

    2,351.00
    +8.50 (+0.36%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,521.11
    +151.77 (+0.30%)
     
  • CMC Crypto 200

    1,393.23
    -3.30 (-0.24%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

Why Ingevity (NGVT) is a Top Growth Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.

Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to use the Zacks Style Scores, which are indicators that rate stocks based on three widely-followed investing types: value, growth, and momentum.

Why This 1 Growth Stock Should Be On Your Watchlist

Different than value or momentum investors, growth-oriented investors are concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, they'll want to focus on the Growth Style Score, which analyzes characteristics like projected and historical earnings, sales, and cash flow to find stocks that will see sustainable growth over time.

ADVERTISEMENT

Ingevity (NGVT)

Based in North Charleston, SC, Ingevity Corporation is a global producer of high performance activated carbon materials and specialty chemicals. The company provides innovative solutions through proprietary formulated products. Ingevity started trading in May 2016 after its spinoff from the WestRock Company.

NGVT is a Zacks Rank #2 (Buy) stock, with a Growth Style Score of B and VGM Score of B. Earnings are expected to grow 15.7% year-over-year for the current fiscal year, with sales growth of 15%.

Two analysts revised their earnings estimate upwards in the last 60 days for fiscal 2022. The Zacks Consensus Estimate has increased $0.10 to $6.05 per share. NGVT boasts an average earnings surprise of 16.3%.

On a historic basis, Ingevity has generated cash flow growth of 20.3%, and is expected to report cash flow expansion of 5.5% this year.

With solid fundamentals, a good Zacks Rank, and top-tier Growth and VGM Style Scores, NGVT should be on investors' short lists.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Ingevity Corporation (NGVT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research